Lam Research is in a powerful long-term uptrend, with the stock surging 255.6% over the past year, dramatically outperforming the S&P 500's 19.1% gain. The current price of $351.41 sits at 80.2% of its 52-week range (low $90.94, high $438.50), indicating strong momentum but still below the peak, suggesting room for further upside if the trend continues. The stock's beta of 1.805 implies it is 80.5% more volatile than the market, amplifying both gains and losses. Short-term momentum remains robust, with a 1-month gain of 5.1% and a 3-month gain of 60.9%, though the 1-month pace has decelerated from the explosive 3-month run. The 1-year relative strength of 236.5% versus the S&P 500 underscores sustained outperformance, but the recent pullback from the June high of $433.33 to $351.41 (down 18.9%) suggests profit-taking or consolidation after a parabolic move. The 52-week low of $90.94 provides a distant support level, while the 52-week high of $438.50 is the immediate resistance. A breakout above $438.50 would signal a resumption of the uptrend and likely target new highs, while a breakdown below the recent June low of $303.28 could indicate a deeper correction. With a beta of 1.805, the stock is highly sensitive to market swings, requiring careful risk management.

Lam Research's revenue trajectory is accelerating strongly, with the most recent quarter (Q2 FY2026, ended Dec 28, 2025) reporting $5.34 billion, up 22.1% year-over-year. This marks a significant acceleration from the prior year's growth rates, as revenue has climbed from $3.79 billion in Q3 FY2024 to $5.34 billion over six quarters. The growth is driven by both System sales ($3.36 billion) and Customer Support ($1.99 billion), reflecting broad-based demand for AI-capable chip manufacturing equipment. The company is highly profitable, with net income of $1.59 billion in the latest quarter and a net margin of 29.8%. Gross margin has expanded to 49.6% from 47.4% a year ago, while operating margin improved to 33.9% from 30.5%, demonstrating operating leverage. The trailing twelve-month free cash flow is $6.66 billion, providing ample liquidity. The balance sheet is strong, with a current ratio of 2.21, debt-to-equity of 0.48, and ROE of 54.3%. The company generates substantial cash, funding both capital expenditures ($185 million in Q2) and shareholder returns ($1.47 billion in buybacks and $328 million in dividends in Q2). The FCF yield of approximately 5.3% (based on market cap of $125 billion) is attractive for a growth company.